No products in the cart.

Anti-ESR1 antibody

SKU Product Brand Unit Availability Price Quantity  
AB-06-1606
Anti-ESR1 antibody
Erpan Tech In stock

Specifications        

Product type: Primary antibody
Antigen: ESR1
Immunogen: This antibody is produced by immunizing rabbits with
a synthetic peptide (KLH-coupled) corresponding to a region of C-terminal
residues of human ESR1.
Species immunized: Rabbit
Isotype: IgG
Applications: Western Blot (1:200-1:2000);Flow Cytometry (1:100-1:200);Immunocytochemistry (1:100-1:200)
Reactivity: Human
Clonality (clone number): Polyclonal
Form: Liquid
Buffer: 1*TBS (pH7.4), 1%BSA, 40%Glycerol. Preservative: 0.05% Sodium Azide.
Concentration: 1mg/ml
Purity: Immunogen affinity purified
Storage: Aliquot and freeze at -20℃. Avoid multiple freeze/thaw cycles.
Alternative names: DKFZp686N23123 antibody
ER alpha antibody
ER antibody
ER-alpha antibody
Era antibody
ESR antibody
ESR1 antibody
ESR1_HUMAN antibody
ESRA antibody
Estradiol receptor antibody
Estrogen nuclear receptor alpha antibody
Estrogen receptor 1 antibody
Estrogen receptor alpha 3*,4,5,6,7*/822 isoform antibody
Estrogen receptor alpha antibody
Estrogen receptor alpha delta 3*,4,5,6,7*,8*/941 isoform antibody
Estrogen receptor alpha delta 3*,4,5,6,7*/819 2 isoform antibody
Estrogen receptor alpha delta 4 +49 isoform antibody
Estrogen receptor alpha delta 4*,5,6,7*/654 isoform antibody
Estrogen receptor alpha delta 4*,5,6,7,8*/901 isoform antibody
Estrogen receptor alpha E1 E2 1 2 antibody
Estrogen receptor alpha E1 N2 E2 1 2 antibody
Estrogen receptor antibody
ESTRR antibody
NR3A1 antibody
Nuclear receptor subfamily 3 group A member 1 antibody
Show More

Target information

Nuclear hormone receptor. The steroid hormones and their receptors are involved in the regulation of eukaryotic gene expression and affect cellular proliferation and differentiation in target tissues. Ligand-dependent nuclear transactivation involves either direct homodimer binding to a palindromic estrogen response element (ERE) sequence or association with other DNA-binding transcription factors, such as AP-1/c-Jun, c-Fos, ATF-2, Sp1 and Sp3, to mediate ERE-independent signaling. Ligand binding induces a conformational change allowing subsequent or combinatorial association with multiprotein coactivator complexes through LXXLL motifs of their respective components. Mutual transrepression occurs between the estrogen receptor (ER) and NF-kappa-B in a cell-type specific manner. Decreases NF-kappa-B DNA-binding activity and inhibits NF-kappa-B-mediated transcription from the IL6 promoter and displace RELA/p65 and associated coregulators from the promoter.

Provider

Erpantech Laboratory